175 related articles for article (PubMed ID: 18444627)
21. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.
Xie H; Qiu K; Xie X
Int J Mol Sci; 2014 Nov; 15(11):20927-47. PubMed ID: 25405729
[TBL] [Abstract][Full Text] [Related]
22. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
24. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
Kumar V; Saha A; Roy K
Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
Jiang Y; Gao H
Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
[TBL] [Abstract][Full Text] [Related]
26. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs.
Wu HQ; Yao J; He QQ; Chen FE
SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254
[TBL] [Abstract][Full Text] [Related]
27. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
[TBL] [Abstract][Full Text] [Related]
28. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
Dowlati Beirami A; Hajimahdi Z; Zarghi A
J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
[TBL] [Abstract][Full Text] [Related]
29. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
[TBL] [Abstract][Full Text] [Related]
30. Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.
Teixeira C; Gomes JR; Couesnon T; Gomes P
J Comput Aided Mol Des; 2011 Aug; 25(8):763-75. PubMed ID: 21786172
[TBL] [Abstract][Full Text] [Related]
31. Homology model-guided 3D-QSAR studies of HIV-1 integrase inhibitors.
Sharma H; Cheng X; Buolamwini JK
J Chem Inf Model; 2012 Feb; 52(2):515-44. PubMed ID: 22256860
[TBL] [Abstract][Full Text] [Related]
32. Receptor based 3D-QSAR to identify putative binders of Mycobacterium tuberculosis Enoyl acyl carrier protein reductase.
Kumar A; Siddiqi MI
J Mol Model; 2010 May; 16(5):877-93. PubMed ID: 19779936
[TBL] [Abstract][Full Text] [Related]
33. 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.
Xu HR; Fu L; Zhan P; Liu XY
SAR QSAR Environ Res; 2016 Dec; 27(12):999-1014. PubMed ID: 27667445
[TBL] [Abstract][Full Text] [Related]
34. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
35. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
Chaudhaery SS; Roy KK; Saxena AK
J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
[TBL] [Abstract][Full Text] [Related]
36. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method.
Li YP; Weng X; Ning FX; Ou JB; Hou JQ; Luo HB; Li D; Huang ZS; Huang SL; Gu LQ
J Mol Graph Model; 2013 Apr; 41():61-7. PubMed ID: 23500628
[TBL] [Abstract][Full Text] [Related]
37. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lu P; Wei X; Zhang R
Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
[TBL] [Abstract][Full Text] [Related]
38. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
[TBL] [Abstract][Full Text] [Related]
39. Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.
Cao H; Cao R; Zhang H; Zheng X; Gao D
Curr Med Chem; 2008; 15(15):1462-77. PubMed ID: 18537623
[TBL] [Abstract][Full Text] [Related]
40. Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.
Jabeen F; Oliferenko PV; Oliferenko AA; Pillai GG; Ansari FL; Hall CD; Katritzky AR
Eur J Med Chem; 2014 Jun; 80():228-42. PubMed ID: 24780600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
